Evidence map›Paper›PMID 39712766›Full record

ArticleCureus2024

Challenges in Diagnosing Hepatic Sarcoidosis: A Case Report.

Adil Zegmout, Ayman El Farouki, Aniss Rafik, Amine Elwardi, Mohamed Essarghini

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adil ZegmoutFaculty of Medicine and Pharmacy, Hassan II University, Casablanca, MAR.
Ayman El FaroukiRadiology Department, Hassan II Military Hospital, Laayoune, MAR.
Aniss RafikPulmonology Department, Mohamed V Military Hospital, Rabat, MAR.
Amine ElwardiPathology Department, Annasr Pathology Center, Laayoune, MAR.
Mohamed EssarghiniFaculty of Medicine and Pharmacy, Hassan II University, Casablanca, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic sarcoidosis is rare, and its similarity to liver metastases complicates the diagnosis. This mimicry requires a thorough diagnostic investigations to exclude neoplasia and other granulomatous diseases, particularly tuberculosis. A 36-year-old male presented with a two-month history of right hypochondrial tenderness, anorexia, asthenia, and weight loss. Clinical examination showed hepatomegaly and splenomegaly. A CT scan revealed non-compressive mediastinal lymphadenopathy and nodular hepatosplenomegaly. Liver function tests indicated cholestasis. The differential diagnosis included lymphoma, metastases, tuberculosis, and sarcoidosis. Biological assessments were normal except for elevated serum angiotensin-converting enzyme (120 U/L) and hypoalbuminemia with polyclonal hypergammaglobulinemia. A CT-guided liver biopsy showed non-caseating granulomas. Tuberculosis tests, including acid-fast bacilli, GeneXpert (Cephei Corp., Sunnyvale, CA) cultures, and Quantiferon (QIAGEN, Venlo, Netherlands) were negative. Multidisciplinary discussion supported sarcoidosis based on clinical, biological, radiological, and histological findings. Hepatic sarcoidosis can mimic conditions like tuberculosis and metastases. Accurate diagnosis is crucial for appropriate management, highlighting the need for awareness of atypical presentations.

Indexed as

diagnostic challengesdifferential diagnosisgranulomatous diseasehepatic sarcoidosismultidisciplinary approach

Identifiers

PMID39712766
PMCPMC11663534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.